MAPT and Alzheimer disease: AD is defined by the presence of specific markers in the cerebral cortex, namely, neuritic plaques, which are mostly composed of fibrillary amyloid-β (Aβ), and abundant neurofibrillary tangles, which are composed of hyperphosphorylated Tau protein (pTau) [1,2].